血必净注射液治疗重度急性一氧化碳中毒30例临床分析

目的:探讨血必净注射液治疗重度急性一氧化碳中毒的临床疗效。方法:60例重度急性一氧化碳中毒患者随机分为治疗组和对照组各30例,对照组给予高压氧等常规治疗,治疗组在常规治疗基础上加用血必净注射液,比较两组临床疗效。结果:治疗组患者神志清醒时间较对照组明显缩短(P0.01);治疗组总有效率高于对照组(P0.05);治疗组急性一氧化碳中毒迟发性脑病发生率明显低于对照组(P0.05)。结论:在常规治疗的基础上,合用血必净注射液治疗重度急性一氧化碳中毒可提高临床疗效,减少急性一氧化碳中毒迟发性脑病的发生率。

The Clinical Analysis of 30 Patients with Acute Severe Carbon Monoxide Poisoning Treated by Xuebijing Injection

Objective：To explore the clinical efficacy of Xuebijing Injection in treatment of patients with acute severe carbon monoxide poisoning. Methods： 60 patients with acute severe carbon monoxide poisoning were randomly divided into treatment group and control group,each group was 30 cases.The control group received the conventional treatment of hyperbaric oxygen and treatment group was added Xuebijing Injection on the basis of conventional therapy.The clinical efficacy was compared between the two groups. Results： The awake time and the rate of delayed encephalopathy after acute carbon monoxide poisoning in the treatment group were significantly shorter than those in the control group （P 〈 0.05）.The total effective rate in the treatment group was significantly higher than that in the control group（P 〈 0.05）. Conclusion： On the basis of conventional therapy, Xuebijing Injection can improve the clinical efficacy and reduce the rate of delayed encephalopathy after acute carbon monoxide poisoning in treatment of acute severe carbon monoxide poisoning.